Skip to content

A study comparing effectiveness of dexamethasone with prednisolone in children with acute exacerbation of asthma

Comparative efficacy of oral dexamethasone with prednisolone in children with acute exacerbation of asthma - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094899
Enrollment
80
Registered
2025-09-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

Intervention1: Dexamethasone: Dexamethasone in a dosage of 0.3mg/kg/day (Max: 16mg/day) Frequency: Once daily Route: Oral Duration: 2 days Control Intervention1: Prednisolone: Prednisolone, in a dosag

Sponsors

Government Medical College and Hospital Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between the ages of 2 years to less than 18 years hospitalized with acute exacerbation of asthma.

Exclusion criteria

Exclusion criteria: Life threatening exacerbation requiring PICU admissions. Known hypersensitivity to dexamethasone or prednisolone. Chronic comorbidities (e.g., congenital heart disease, immunodeficiencies). Prior corticosteroid use in the last 30 days Children already enrolled in the study and presenting within 30 days of discharge from hospital.

Design outcomes

Primary

MeasureTime frame
Change in mean PRAM scoresTimepoint: Baseline (admission) and day 4 of treatment

Secondary

MeasureTime frame
Pediatric Respiratory Assessment Measure, measured 6 hourly till discharge or transfer from emergency departmentTimepoint: 6 hourly till discharge;Length of hospital stayTimepoint: admission to discharge;Incidence of adverse effectsTimepoint: admission to discharge;Unscheduled visits to hospital due to symptoms of exacerbation asthma within 60 days of administration of steroidsTimepoint: discharge to 60 days after discharge;Persistence of symptoms after 7 days of discharge.Timepoint: discharge till 7 days after discharge;Duration of admission in emergency departmentTimepoint: admission to discharge

Countries

India

Contacts

Public ContactDr Pryas Jain

Government medical college, Chandigarh

drpankaj.kr@gmail.com8894286467

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026